Clinical Profiles and the Outcomes of Burn Patients Admitted to the Burn Unit of Jimma Medical Center

Figures & data

Table 1 Sociodemographic, Place of Burn of Occurrence, Predisposing Conditions, and Season of Admission of the Participants

Variables		Frequency	Percentage
Sex	Male	60	48.4
	Female	64	51.6
Age, years	<14	51	41.1
	15–29	48	38.7
	30–44	16	12.9
	>45	9	7.3
Residence	Urban	38	30.6
	Rural	86	69.4
Place of injury	Home	77	62.1
	Work	34	27.4
	Street	13	10.5

Table 2 Etiology Distribution by Gender and Age

Etiology	Scald	Flame	Electricity	Contact	Gasoline	Chemical	Total
Sex n (%)
Male	14 (23.7%)	21 (56.8%)	11 (100.0%)	4 (57.1%)	6 (100.0%)	4 (100.0%)	60 (48.4%)
Female	45 (76.3%)	16 (43.2%)	–	3 (42.9%)	–	–	64 (51.6%)
M:F ratio	1: 3.11	1.3:1		1.3:1
Age, years, n (%)
<14	38 (64.4%)	7 (18.9%)	1 (9.1%)	5 (71.4%)	–	-	51 (41.13%)
15–29	18 (30.5%)	20 (54.1%)	5 (45.5%)	1 (14.3%)	1 (14.3%)	3 (75.0%)	48 (38.71%)
30–45	2 (3.4%)	5 (13.5%)	4 (36.4%)	-	4 (66.7%)	1 (25.0%)	16 (12.9%)
>45	1 (1.7%)	5 (13.5%)	1 (9.1%)	1 (14.3%)	1 (16.7%)	-	9 (7.26%)
Total, n (%)	59 (47.6%)	37 (29.8%)	11 (8.9%)	7 (5.6%)	6 (4.8%)	4 (3.2%)	124 (100%)

Notes: n= number, (-) = not reported, % = percent.

Table 3 Burn Predisposing Conditions and Season of the Occurrence

		Number	Frequency
Predisposing conditions	Epilepsy	22	17.7
	Psychiatric	4	3.2
	Substance use	3	2.4
	Disability	1	0.8
Season of admission	Winter	41	33.1
	Spring	32	25.8
	Autumn	28	22.6
	Summer	23	18.5

Figure 1 Anatomic sites of burn among patients.

Table 4 Etiology Against the TBSA Burn

Etiology	Number	Mean±SD
Scald	48	13.41±5.06
Flame	27	14.77±5.24
Electricity	8	15.0±5.53
Contacts	6	11.33±3.72
Gasoline	5	18.6±2.2
Chemical	3	13.33±4.61

Abbreviation: SD, standard deviation.

Table 5 Patterns of IV Fluids Used, Tetanus Anti-Toxoid, and Analgesics Prescription Among Burn Patients

IV Fluids	Number	Percentage
Lactated ringer	86	69.4
Normal saline	80	64.5
40% Dextrose	2	1.6
5% Dextrose in water	1	0.8
Analgesics
Tramadol	88	71.0
Diclofenac	54	43.5
Paracetamol	27	21.8
Morphine	7	5.6
Tetanus anti-toxoid (TAT)	7	5.6

Figure 2 Proportion of the surgical procedures done for the burn patients.